Priority Date: 23.12.11 (EP 20110306766)

PEPTIDES TARGETING RECEPTOR ACTIVATOR OF NUCLEAR FACTOR -KAPPA B (RANK) AND THEIR APPLICATIONS

  • Application ID: EP12810302
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Applicants

Research organisation logo small
Research Organisation

Attorney

Employment test 201 - 500 employees
Company dna regimbeau
operating since 1931
Headquarter in Paris and 8 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Cabinet Regimbeau is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 173 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 23.12.2011 - Priority Date (EP 20110306766)
  • 27.06.2013 - Publication A1 (WO2013093039)
  • 17.12.2014 - Publication A1 (EP2812015)
  • 13.04.2016 - Publication B1 (EP2812015)